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It was  shown recently (1)  that  certain synthetic polyglucoses (2)  yielded 
precipitates with the antibodies in a  number of antipneumococcal horse sera, 
notably those of Types II, VII,  IX, XII, XVIII, XX,  and XXII.  Since the 
constituent sugars and the structure of the type-specific polysaccharide of the 
first of these pneumococcal types are known,  a  partial  interpretation of the 
results  was  attempted  in  terms  of  Stacey's finding  that  the  glucose in  this 
specific polysaccharide forms branching points with linkages  in  the  1,4  and 
6 positions (3). Such an interpretation appeared tentatively justified because 
the 1,4 and 1,6 linkages are those of most frequent occurrence in the synthetic 
polyglucoses  (2).  It  was  further  inferred  that  glycogens and  amylopectins, 
which both contain branching points of glucose with a-linkages in the 1,4 and 
6 positions, should also react with the same series of antisera. A description is 
given in  the present communication of experiments designed to  test  this in- 
ference. Preliminary qualitative tests at  0-5  °  are shown in Table I. The re- 
mainder of the paper is taken up mainly with quantitative data obtained with 
various  glycogens derived from maize,  the  oyster, and  from animal  organs. 
Quantitative experiments with amylopectins showed irregularities which have 
not yet been traced to their source, so that a  report on these substances will 
be made later. 
EXPERIMENTAL 
Specific Polysaccharides, Antisera, and Estimation of Antibody Nilrogen.--Pneumoeoecal 
specific polysaccharides  were either prepared as described in reference 4 or were obtained 
through the courtesy of E. R. Squibb and Sons, New Brunswick, New Jersey. 
The antisera used were generously  supplied by the Bureau of Laboratories,  New York City 
Department of Health, and by the Division of Laboratories and Research, Department of 
Health, State of New York. 
*This work was carried out under the Harkness Research Fund of the Presbyterian Hospi- 
tal,  New York, and a grant from The Rockefeller  Foundation. 
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Determinations of antibody nitrogen were carried out in duplicate in 8 ml. centrifuge tubes, 
usually at or near 0 ° according to the method in reference 5, except that the washed specific 
precipitates were analyzed according to the Markham method (6). Except for reactions with 
the homologous pneumococcal polysaccharides,  the mixtures were allowed  to stand in the 
refrigerator for 4 to 10 days, with occasional twirling, before analysis. In many instances in 
sera other than Type IX the supernatants deposited additional small amounts of precipitate 
on longer standing and these are included in most of the analyses. 
As in many cross-reactions precipitation of the antisera by glycogen has a large temperature 
coefficient. It became apparent toward the end of the present studies that this effect was un- 
usually large in the glycogen reaction (Fig.  1)  so that closer control of temperature would 
seem desirable and will be undertaken in extensions of the work now under way. 
350  ....... 
250. 
o  200 
"8 
a.  150. 
100 
"~  50~ 
~  25, 
IZ5 t' 
0  ,  23* 
rng. Glycogen Added 
I 
-2t°*l°J  ~ :300 
Ofo5  ° 
200 
I00 
50 
FIG.  1.  Precipitation of  antipneumococcus Type  XII horse serum  by glycogen  at  var- 
ious temperatures. 
Precipitation of A pparenay Normal Sera by Glycogen.--As noted in Table I four presumably 
normal horse sera showed negative to marked precipitation with different samples of glycogen 
and amylopectin. Quantitative analyses with serum a gave 1 to 5 #g. of precipitate nitrogen 
per ml.; sera b and c gave maxima of 10 and 15/~g. per ml., respectively. 
In the meantime Dr. Pierre Grabar of the Pasteur Institute, Paris, has observed interracial 
precipitation with glycogen in many supposedly normal sera. Chicken sera reacted strongly, 
horse sera definitely, human sera occasionally, and rabbit sera weakly or not at all. Quantita- 
tive estimations on the three most reactive horse sera showed 4.5, 6.3, and 20 #g. of precipitate 
nitrogen per ml. Thanks are due Dr. Grabar for permission to mention these results• Two of 
the three sera, therefore, showed roughly the same precipitation as did serum a in the present 
studies; the third serum was about as reactive with glycogen as serum c and precipitated as 
much nitrogen with it as did a potent antipneumococcus Type II serum (Table II). Since the 
broad polyglucose specificity (1)  is by no means confined to the pneumococci (7) it would 
appear possible that the horses in question had been exposed to microorganisms showing this 
specificity and had produced antibodies to them. TABLE  II 
Antibody Nitrogen Precipitated by Fractions of Oyster Glycogen  from 1.0 Ml. Portions of 
Antipneumococcal Horse Sera 
Fraction 
mg. 
A  0.2 
0.5 
1.0 
2.0 
5 
6 
8 
9 
12 
15 
B  0.2 
0.5 
1.0 
2 
2.4 
4 
7.2 
D  0.2 
0.5 
AI  0.2 
0.3 
0.5 
1 
2 
5 
10 
A2  0.3 
1.0 
2 
5 
10 
Antiserum, type 
II  IX  XII  XX  XXII,  No. 243 
~g.  ~g.  ~g.  ~g 
21  28  25  36 
62  68  50  83 
114  122  65  119 
156  180  57*  137 
204  250 
234 
290 
236 
246 
65  42§ 
137  51§ 
32  178  52§ 
36 
230 
56 
236 
14o~ 
32 
57 
94 
113 
2  97  22  20 
2  162  24  31 
30 
58 
107  104 
177  118  130 
259  142 
271  141 
36 
120  45 
164  148  48¶  121 
214  128 
232  239 
With Type VII and Type XVIII antisera, fraction A~ precipitated 7 and 18 gg. of nitrogen, 
respectively. 
* The supernatant gave an additional 33/~g. N  with synthetic potyglucose fraction B(1). 
This precipitated 107 ]~g. N  from the unabsorbed serum. 
The supernatant yielded 24 #g. of precipitate N  with polyglucose B, which precipitated 
164 #g. 1V from the unabsorbed serum. 
§ Analyses after 5 days in the cold.  Small amounts of precipitate formed in the super- 
natants on longer standing but are not included in these instances. 
[[ 2.0 ml. of C-absorbed serum actually used; calculated to 1 ml. 
¶ One determination only. 
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TABLE H--Conduded 
347 
Fraction 
mg. 
0.3 
1 
2 
5 
Homologous  pneumococcal  specific poly- 
saccharide 
Maximum per cent antibody precipitated 
by glycogen 
Antiserumt type 
II 
/~g. 
1811 
1811 
1061 
IX 
13 
51 
74 
52 
1655 
16 
XII 
1820 
16 
XX  XXII, 
No. 242 
44~8  847 
14  17 
It is also to be noted from Table I that four of the antipneumococcus horse sera gave tests 
as weak as those of the least reactive of the so called normal sera. Precipitation of the more 
reactive normal sera is being studied in greater detail. 
Glycogens Used.--Many of the samples of liver glycogens and limit dextrins were generously 
supplied by Dr. Gerry T. Cori, to whom the authors are most grateful. Rat liver glycogen was 
kindly furnished by Dr. Z. Dische. Ascaris glycogen was prepared by Dr. Dan H. Campbell 
and obtained from Dr. Elvin A. Kabat. The glycogens of dog and rabbit livers were prepared 
according to the method outlined in reference 8. The samples of human liver glycogen from 
cases of von Gierke's disease are described in reference 9, and the glycogens from cat and 
rabbit livers and from horse muscle in reference 10. Maize glycogen, sample a, was prepared 
according to the description in reference 11, while sample b was furnished by Dr. T. J. Schoch. 
Oyster glycogen was purchased from the Nutritional Biochemicals Corporation. Both limit 
dextrins in the glycogen series were prepared from rabbit liver glycogen. The suggestion to 
use glycogen from the horse in further tests of the antipneumococcal horse sera was made 
by Dr. N.  W. Pirie at the International Microbiological Congress in Rome. The glycogens 
from horse liver were kindly supplied by Dr. Pierre Grabar and Miss Janine Cour~on. 
Fractlonation of Glycogen.--3 gin. of air-dry oyster glycogen was dissolved in 60 ml. of 5 
per cent sodium acetate solution. The mixture was chilled, centrifuged to remove traces of 
insoluble material, and treated with chilled isopropyl alcohol (4) in an ice bath until a definite 
precipitate (fraction A) formed. This occurred with 21.5 ml. of the alcohol. The mixture was 
allowed to stand in ice water overnight and was centrifuged at 0 °. The supernatant solution 
gave a further precipitate with 10 ml. of isopropyl alcohol (fraction B) and the supernatant 
from this yielded another small fraction (D)  with excess ethyl alcohol. Each fraction was 
dissolved in a little water and reprecipitated with 10 to 20 volumes of redistilled ethyl alcohol. 
The yields were: A, 2.42 gin.; B, 0.03 gin.; D, 0.01 gin. 
Because fractions B and D  possibly represented smaller molecules and showed differences 
of reactivity (Table II) from fraction A this was further ffactionated as follows: 1.85 gm. were 
dissolved in 100 ml. of 5 per cent sodium acetate solution and mixed in the cold with 25 ml. 
of isopropyl alcohol. The precipitate (fraction Al) was centrifuged off in the cold, dissolved 
in 5 ml. of water, and poured into 50 ml. of redistilled ethyl alcohol, filtered off, washed with 
• redistilled alcohol and acetone, and dried; yield, 0.26 gin. Another fraction, A~, was obtained 
from the supernatant from fraction At by addition of 8 nil. of isopropyl alcohol in the cold, and 348  GLYCOGEN~  IMM'UlqOLOGICALLY SPECIFIC  POLYSACCHARIDE 
a fraction, Ah by further addition of ethyl alcohol to a final volume of 200 ml. Each fraction 
was isolated from  concentrated aqueous  solution as above. Yields: A:,  1.27  gm.;  A3, 0.03 
gm. Data obtained with the six fractions are given in Table II. Differences between A~ and 
A~ were small; Aa appeared to be of lower molecular weight, since it was less reactive. 
TABLE  nI 
Quantitative  Analyses of Specific  Predpilation of Various  Antisera by Glycogens from 
Different  Sources 
Source of glycogen 
Maize a, O. 3 mg. 
2  ~¢ 
3 to 4 mg. 
Rabbit liver, 0.5 mg. 
1.2  " 
2.0  " 
6  " 
v.G.1, human liver, 0.5 rag. 
2.0  " 
Cat liver,  1  " 
2  et 
4  tt 
Antiserum, type 
IX  XlI  XX  XXlI, 
No. 243 
Amount N precipitated per ml, 
~g. 
1165 
14(?) 
28 
~121[I 
26 
88 
186 
I~g.  Izg. 
82  35 
184"  59 
144  5o~ 
16s§ 
71 
107 
129 
74 
125¶ 
179 
54 
101 
106 
58 
130 
* One determination only. The superrmtant from this precipitated 660/~g.  N  with poly- 
glucose A; the supernatant from this, 939/~g. N with S XII; total of the three precipitations, 
1783 #g. N. 
1.5 to 2 rag, sample b. With C-absorbed Type IX serum 107 gg.  N  was precipitated, 
almost the same amount as for the unabsorbed serum. 
§ Maize glycogen b used. 
]! One determination only. A freshly prepared solution of the glycogen was used. The other 
values in the Type IX serum were obtained with a  solution 1.5 months old. 
¶  One determination only. 
Supernatants of Types XX and XXII antisera from which maximal antibody had been 
precipitated by synthetic polyglucose fraction A  (1)  gave no precipitate with glycogen frac- 
tion A. 
Effect of Saliva  on the Reactivity  of Glycogen toward Antisera.-4  ml. of human saliva was 
diluted with 4 ml. of saline and centrifuged. 3.5 ml. of the supernatant was added to 3.5 ml. 
of a saline solution of oyster glycogen, fraction A, containing 10 mg. per ml. After 2 hours at 
37  ° 1.0 ml. portions were added in duplicate to 1.0 ml. each of Type IX and Type XII antlsera, M.  HEIDELBERGER~  A.  C.  AISENBERG,  W.  Z.  HASSID  349 
with blank  tubes containing antisera and  saliva without glycogen. Estimation of reducing 
sugars in the digested glycogen according to Schales and Schales (12) showed 3 rag.  per ml. 
7 and 0 pg. of N  were precipitated from the antisera by the digested glycogen, respectively, 
as against 204 and 250 vg. of N precipitated by 5 nag. of undigested fraction A. An analogous 
test of saliva-treated maize glycogen with Type XII antiserum gave a  similar result.  The 
presence of saliva did not prevent precipitation of antibody by the homologous type-specific 
pneumococcal polysaccharide. 
Quantitative Data witk Various Glycogens.--These  are given in Table III. 
Experiments with Repredpitated Glycogens and with Glycogens after Acetylation and Deaxetyla- 
tion.--In order to find out whether the immunological specificity of glycogen could be removed 
by purification portions of dog liver and maize glycogens were reprecipitated and then acety- 
lated by dispersion in formamide and treatment with acetic anhydride and pyridine at room 
TABLE IV 
Reartions of Reprecipitated Glycogens and of Corresponding Acetylaled-Deacetylaled Derivatives 
in AntiOneumococcal Horse Sera 
~ntisers 
~,ntibody N precipitated by glycogen,  rag... 
Dog liver, reprecipitated 
Dog liver, acetylated, deacetylated 
Maize, reprecipitated 
Maize, acetylated, deacetylated 
Maximum per cent of  type-specific 
antibody N precipitated 
Type  IX 
1655 pg. antibody N per ml. 
1  2.5 
lag.  lag. 
83  129 
75  118 
5  10  14 
pg.  pg.  pg. 
157  152" 
148  132"  130" 
9 
Type XXII, No. 566 
878 pg. antibody  N per ml. 
! 
/at. 
63 
45 
2  3 
lag.  pg. 
74  75 
71  73 
9 
1.0  ml.  antiserum  used  in  all  tubes except those marked*,  which contained 0.50  ml. 
Results calculated to 1.0 ml. 
temperature  (13).  The acetyl derivatives were deacetylated with Ba(OMe)=  (14)  and  the 
glycogens recovered by precipitation with alcohol. Comparison of the original and recovered 
materials is made in Table IV. 
DISCUSSION" 
Intimations  that  glycogens from  various  species  of higher  animals,  from 
clams, and from Ascaris, might have antigenic properties may be found in the 
literature (15). Ikeda showed that the sera of rabbits injected with large quan- 
tities of rather crude horse liver or dog liver glycogen fixed complement with 
either glycogen and also gave weak precipitation. Fixation of complement was 
much less with rabbit liver glycogen but appreciable precipitation  occurred. 
The possibility that  these reactions were due to cross-reactivities of protein 
impurities  is not ruled out by the negative experiments recorded with liver 
proteins probably denatured  by extraction  with  alkali  and  precipitation  by 
trichloroacetic acid.  Possibly, too, the reactions were similar  to the relatively 
weak ones observed in the current studies with supposedly normal sera (page 350  GLYCOGEN,  IMMUNOLOGICALLY  SPECIFIC POLYSACCHARIDE 
344, Table I). Nor is there any statement that the reactions were abolished by 
enzymatic destruction of the glycogen. This objection also applies  to Camp- 
bell's studies on clam and Ascaris glycogens, while there is also the possibility 
that  other  immunologically  specific polysaccharides were  contained  in  the 
preparations. The antigenicity of glycogen therefore remains in doubt. 
The present studies, however, clearly establish the reactivity of amylopectin 
and of glycogens of diverse origins, even from the horse, toward certain pre- 
formed antibodies,  notably those in horse antisera to the pneumococcal Types 
II, IX, XII, XX, and XXII. Because of the precipitation of antibodies in the 
designated sera by certain synthetic polyglucoses  (1) and the dextrans (16), 
all of which possess glucose units linked together by a-l,6 and a-1,4 bonds, 
glycogen and amylopectin were tested in the same sera after Stacey's finding 
that the glucose in the specific polysaccharide of the Type II pneumococcus 
consists of glucose linked at the  i,4  and  6  positions  (3).  The presence of 
a-1,4,6 branch points in glycogen and amylopectin made this reactivity ap- 
pear almost inevitable on the basis of chemical relationship and the quantita- 
tive theory of specific immune precipitation (17) and agglutination (18) which 
postulates multiple reactive groupings on both antigen and antibody. Earlier 
instances of the relation between the chemical constitution of immunologically 
reactive polysaccharides and their cross-reactivity in different antisera are the 
precipitation of Types II and HI antipneumococcal sera by gum arabic and 
its derivative from which one-half of the arabinose had been removed (19), 
reactions of other plant gums in antipneumococcal sera (20), the cross-reac- 
tion between Types III and VIII pneumococcus which has been studied quan- 
titatively in detail (21), the reaction of the polysaccharide of PJ~izobium radi- 
cicolum in Type III antipneumococcal serum (21 a), the reaction between the 
blood group A substance and Type XIV antipneumococcal sera (22), and the 
relation of the removal of fucose from this substance to the cross-reaction  (23). 
The question immediately arises  whether the precipitates observed in the 
various sera are due to glycogen itself or to other polysaccharides present as 
impurities. Answers were sought by fractionation of oyster glycogen,  avail- 
able in relatively large quantity, by destruction of glycogens with saliva,  and 
by conversion of glycogens into their acetyl derivatives and subsequent de- 
acetylation. Fractionation from sodium acetate solution by means of isopropyl 
alcohol  (4) yielded only small fractions which differed appreciably from the 
principal one (Table II) in serological properties. All fractions precipitated the 
antisera, although the curves of precipitation were often relatively different 
in the different antisera.  Possibly fraction AI was larger in molecular size, 
and fractions B, D, and Aa smaller than the main fraction, As. 
Since the reactions measured were all cross-reactions, it is not surprising that 
relatively large amounts of glycogen were required to precipitate the maximal 
quantity of antibody and that much less antibody was precipitated at room 
temperature (Fig.  1) or 37  ° than at 0  ° (cf., for example, reference 21). M.  HEIDELBERGER,  A.  C.  AISENBERG~ W.  Z.  HASSID  351 
As for the enzymatic destruction of glycogen, treatment of oyster and maize 
glycogens,  the oniy ones tested,  with saliva rapidly and effectively destroyed 
their capacity to precipitate antisera.  Control  tests with antisera  containing 
saliva showed that the enzymes did not interfere with the precipitation of the 
antibody by the homologons  type-specific  polysacchatide,  so that  it  was  in 
reality the glycogen and its precipitating power that had been affected. 
Reprecipitation of maize and dog liver glycogens and conversion of the puri- 
fied substances into their acetyl derivatives followed by deacetylation, led  to 
products  which  precipitated  almost  as  much  antibody as  did  the  original, 
purified glycogens  (Table IV).  The small  differences  observed were doubtless 
due to some degree of depolymerization during chemical manipulations  which 
have been shown to degrade a specific polysaccharide such as that of Type Ill 
pneumococcus (24). 
If it be granted, then, that the observed precipitation of antisera is due to 
the glycogen itself, it might still be considered  that the reactions of the various 
glycogens were non-specific and that globulins  other than antibody were pre- 
cipitated.  Evidence against  this  interpretation  is:  (a)  the negative or weak 
reactions in  two normal  horse sera and  the Type III,  XVIII, XXVII,  and 
XXVIII antipneumococcus horse sera (Table I); (b) the data in the footnotes 
of Tables II and Ill showing reductions in the amounts of nitrogen precipitated 
by polyglucose fractions after prior precipitation of the sera with a glycogen, 
it having been shown in reference  i  that only antibody is precipitated by the 
polyglucoses; and  (c) the figures in a footnote to Table Ill showing  that  the 
sum of the quantities of nitrogen precipitated by glycogen,  polyglucose,  and 
type-specific  polysaccharide,  in  succession,  equals  the  amount  of  antibody 
nitrogen precipitated from unabsorbed serum by an excess of the type-specific 
polysaccharide alone. The data under (b) show also that glycogen precipitates 
a portion of the same antibody which reacts with synthetic polyglucose frac- 
tions A and B. 
The true chemical  basis of the cross-reactivity of the glycogens in the anti- 
sera to pneumococci of Types VII, IX, XII, XX, and XXII must remain in 
doubt until the presently unknown constituent sugars of the specific capsular 
polysaccharides of these types are identified  and the nature of the linkages  be- 
tween the sugars has been revealed. A beginning is being made on this formida- 
ble task. It is quite possible that multiple recurrence of a-I, 6 linkages  in the 
glycogen may suffice to ensure cross-reactivity in one or more sera, while a-1,4 
linkages,  or both a-1,4 and  a-l,6  linkages  may be required  to precipitate 
the  antibody in  another,  and  ~-1,4,6  branch  points  might  be essential  in 
others. This would seem to be the case in the cross-reaction  of glycogen with 
Type II antiserum, since the specific polysaccharide of Type II pneumococcus 
appears to contain all of its glucose linked in the 1,4 and 6 positions (3). While 
it might on first thought be considered  strange that less than 2 per cent of the 
antibody in the Type II serum was precipitated by glycogen it must be remem- 352  GLYCOGEN,  IIKMUNOLOGICALLY  SPECIFIC POLYSACCHARIDE 
bered that glucose makes up only about 30 per cent of the Type II specific 
polysacdaaride,  while 50 per cent is rhamnose (25) and about 20 per cent pre- 
sumably glucuronic  acid  (3).  It might more appropriately be considered  re- 
markable that the a-1,4,6 branch points of the glycogens, spaced as they are, 
8  to  15 sugar  units apart,  suffice  to fit closely enough in multiples with the 
Type II antibody to bring about any degree  of precipitation. 
Presumably the specific polysaccharides of Types IX, XII, XX, and XXII 
will be found to be more closely related to glycogen, since higher percentages 
of antibody are precipitated from these sera by glycogen than from the Type 
II serum. The occurrence of glucose in the polysaccharides of these pneumococ- 
e~l types is probable but by no means certain.  In the first place, glucosamine 
may be immunologically equivalent to glucose; secondly, Morgan has found 
instances of inhibition of precipitation of a blood group substance and homolo- 
gous antibody by sugars  and sugar derivatives not obviously related  to the 
antigen (26). Until, therefore, more structural evidence is available any assign- 
ment of explicit relationships  would appear premature. 
SUMMARY 
Glycogens  from  various  animal  and  vegetable  sources  precipitate  anti- 
pneumococcal horse sera of Types II, VII, IX, XII, XX, and XXII. 
Fractionated glycogen and glycogen recovered after reprecipitation, acetyla- 
tion,  and  deacetylafion precipitate  the  antisera, but glycogen  degraded by 
saliva does not. 
A fraction of the antibody is precipitated in the antisera by glycogen. 
Possible  chemical  relationships  accounting  for  these  instances  of  cross- 
precipitation are discussed in terms of the structures of glycogen and the type- 
specific polysaccharides of pneumococcus and the quantitative theory of specific 
precipitation. 
Amylopectin also gives cross-reactions of smaller magnitude. Quantitative 
data on these are withheld until irregularities have been eliminated. 
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